Data Foundry

Drug recalls 2026

Vancomycin HCI — Class II drug recall D-0441-2026

Ongoing recall by Fagron Compounding Services, reported 2026-04-15, distributed nationwide. Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Recall numberD-0441-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmFagron Compounding Services, Wichita, KS, United States
Recall initiated2026-03-20
Classified2026-04-07
Reported by FDA2026-04-15
DistributedNationwide (US)
Quantity16,130 bags
Reason classessterility, device malfunction
NDC71266-5085-01
Lot numbersC274-000049194, C274-000049591, C274-000049592, C274-000049823, C274-000050301, C274-000050411, C274-000050858, C274-000051018, C274-000051056
Expiration dates2026-04-20, 2026-05-09, 2026-05-18, 2026-06-08, 2026-06-13, 2026-07-06, 2026-07-13, 2026-07-18

Product

Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01

Reason for recall

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0441-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.